Kristine Ball

2017

In 2017, Kristine Ball earned a total compensation of $996.3K as Senior Vice President, Corporate Strategy and Chief Financial Officer at VYNE Therapeutics.

Compensation breakdown

Bonus$53,200
Option Awards$825,066
Salary$118,030
Total$996,296

Ball received $825.1K in option awards, accounting for 83% of the total pay in 2017.

Ball also received $53.2K in bonus and $118K in salary.

Rankings

In 2017, Kristine Ball's compensation ranked 8,988th out of 14,666 executives tracked by ExecPay. In other words, Ball earned more than 38.7% of executives.

ClassificationRankingPercentile
All
8,988
out of 14,666
39th
Division
Manufacturing
3,441
out of 5,772
40th
Major group
Chemicals And Allied Products
1,176
out of 2,075
43rd
Industry group
Drugs
940
out of 1,731
46th
Industry
Pharmaceutical Preparations
737
out of 1,333
45th
Source: SEC filing on May 10, 2019.

Ball's colleagues

We found two more compensation records of executives who worked with Kristine Ball at VYNE Therapeutics in 2017.

2017

Steven Basta

VYNE Therapeutics

Chief Executive Officer

2017

Mary Spellman

VYNE Therapeutics

Chief Medical Officer

News

In-depth

You may also like